June 17, 2020 / 12:46 AM / 18 days ago

BRIEF-FDA Revokes Emergency Use Authorization for Chembio Antibody Test

June 16 (Reuters) - Chembio Diagnostics Inc:

* FDA SAYS REVOKES EMERGENCY USE AUTHORIZATION FOR CHEMBIO ANTIBODY TEST

* FDA - REVOKED EUA OF CHEMBIO SYSTEM DPP COVID-19 IGM/IGG SYSTEM, A SARS-COV-2 ANTIBODY TEST, DUE TO PERFORMANCE CONCERNS WITH ACCURACY OF TEST Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below